SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/29/19 Nymox Pharmaceutical Corp 20-F 12/31/18 107:5.1M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual Report by a Foreign Non-Canadian Issuer HTML 837K 4: EX-13.A Annual or Quarterly Report to Security Holders HTML 24K 5: EX-13.B Annual or Quarterly Report to Security Holders HTML 25K 2: EX-12.A Statement re: Computation of Ratios HTML 30K 3: EX-12.B Statement re: Computation of Ratios HTML 30K 12: R1 Document and Entity Information HTML 58K 13: R2 Consolidated Statements of Financial Position HTML 86K 14: R3 Consolidated Statements of Financial Position HTML 27K (Parenthetical) 15: R4 Consolidated Statements of Comprehensive Income HTML 76K 16: R5 Consolidated Statements of Changes in Equity HTML 69K 17: R6 Consolidated Statements of Cash Flow HTML 90K 18: R7 Business Activities and Basis of Presentation HTML 36K 19: R8 Going Concern Considerations HTML 29K 20: R9 Significant Estimates HTML 27K 21: R10 Significant Accounting Policies HTML 70K 22: R11 New Accounting Standards and Interpretations HTML 38K 23: R12 Property and Equipment HTML 88K 24: R13 Intangible Assets HTML 28K 25: R14 Accounts Payable and Accrued Liabilities HTML 38K 26: R15 Convertible Notes HTML 39K 27: R16 Commitments and Contingencies HTML 44K 28: R17 Share Capital HTML 40K 29: R18 Stock Options HTML 50K 30: R19 Share Based Compensation HTML 36K 31: R20 Warrants HTML 58K 32: R21 Income Taxes HTML 75K 33: R22 Earnings Per Share HTML 34K 34: R23 Financial Instruments Fair Value Disclosures HTML 28K 35: R24 Finance Income and Finance Costs HTML 48K 36: R25 Segment Disclosures HTML 43K 37: R26 Concentrations HTML 31K 38: R27 Related Party Transactions HTML 39K 39: R28 Research and Development Expenses HTML 39K 40: R29 Personnel Expenses HTML 36K 41: R30 Capital Disclosures and Financial Risk HTML 29K 42: R31 Foreign Exchange Risk HTML 28K 43: R32 Credit Risk HTML 30K 44: R33 27. Interest Rate Risk HTML 27K 45: R34 28. Liquidity Risk HTML 40K 46: R35 29. Subsequent Events HTML 28K 47: R36 Significant Accounting Policies (Policies) HTML 121K 48: R37 Significant Accounting Policies (Tables) HTML 29K 49: R38 Property and Equipment (Tables) HTML 87K 50: R39 Accounts Payable and Accrued Liabilities (Tables) HTML 36K 51: R40 Convertible Notes (Tables) HTML 35K 52: R41 Commitments and Contingencies (Tables) HTML 43K 53: R42 Share Capital (Tables) HTML 36K 54: R43 Stock Options (Tables) HTML 55K 55: R44 Share Based Compensation (Tables) HTML 33K 56: R45 Warrants (Tables) HTML 55K 57: R46 Income Taxes (Tables) HTML 74K 58: R47 Earnings Per Share (Tables) HTML 33K 59: R48 Finance Income and Finance Costs (Tables) HTML 47K 60: R49 Segment Disclosures (Tables) HTML 42K 61: R50 Concentrations (Tables) HTML 31K 62: R51 Related Party Transactions (Tables) HTML 35K 63: R52 Research and Development Expenses (Tables) HTML 38K 64: R53 Personnel Expenses (Tables) HTML 36K 65: R54 Liquidity risk (Tables) HTML 38K 66: R55 Significant Accounting Policies (Details) HTML 33K 67: R56 Property and Equipment (Details) HTML 61K 68: R57 Property and Equipment (Details Narrative) HTML 28K 69: R58 Intangible Assets (Details Narrative) HTML 37K 70: R59 Accounts Payable and Accrued Liabilities (Details) HTML 33K 71: R60 Convertible Notes (Details) HTML 31K 72: R61 Convertible Notes (Details Narrative) HTML 39K 73: R62 Commitments and Contingencies (Details) HTML 36K 74: R63 Commitments and Contingencies (Details 1) HTML 33K 75: R64 Commitments and Contingencies (Details 2) HTML 35K 76: R65 Commitments and Contingencies (Details Narrative) HTML 38K 77: R66 Share Capital (Details) HTML 29K 78: R67 Share Capital (Details Narrative) HTML 38K 79: R68 Stock Options (Details) HTML 50K 80: R69 Stock Options (Details 1) HTML 43K 81: R70 Stock Options (Details Narrative) HTML 29K 82: R71 Share Based Compensation (Details) HTML 34K 83: R72 Share Based Compensation (Details Narrative) HTML 37K 84: R73 Warrants (Details) HTML 45K 85: R74 Warrants (Details Narrative) HTML 35K 86: R75 Income Taxes (Details) HTML 44K 87: R76 Income Taxes (Details 1) HTML 32K 88: R77 Income Taxes (Details 2) HTML 83K 89: R78 Income Taxes (Details Narrative) HTML 28K 90: R79 Earnings Per Share (Details) HTML 31K 91: R80 Financial Instruments Fair Value Disclosures HTML 26K (Details Narrative) 92: R81 Finance Income and Finance Costs (Details) HTML 46K 93: R82 Segment Disclosures (Details) HTML 43K 94: R83 Concentrations (Details) HTML 32K 95: R84 Related Party Transactions (Details) HTML 37K 96: R85 Related Party Transactions (Details Narrative) HTML 36K 97: R86 Research and Development Expenses (Details) HTML 40K 98: R87 Personnel Expenses (Details) HTML 36K 99: R88 Capital Disclosures and Financial Risk (Details HTML 41K Narrative) 100: R89 Foreign Exchange risk (Details Narrative) HTML 27K 101: R90 Credit risk (Details Narrative) HTML 33K 102: R91 Interest rate risk (Details Narrative) HTML 26K 103: R92 Liquidity risk (Details) HTML 37K 104: R93 Subsequent Events (Details Narrative) HTML 39K 106: XML IDEA XML File -- Filing Summary XML 195K 105: EXCEL IDEA Workbook of Financial Reports XLSX 100K 6: EX-101.INS XBRL Instance -- nymx-20181231 XML 1.72M 8: EX-101.CAL XBRL Calculations -- nymx-20181231_cal XML 142K 9: EX-101.DEF XBRL Definitions -- nymx-20181231_def XML 469K 10: EX-101.LAB XBRL Labels -- nymx-20181231_lab XML 895K 11: EX-101.PRE XBRL Presentations -- nymx-20181231_pre XML 742K 7: EX-101.SCH XBRL Schema -- nymx-20181231 XSD 294K 107: ZIP XBRL Zipped Folder -- 0001640334-19-000464-xbrl Zip 132K
Download this zipped .zip folder | |
Files: | nymx-20181231.xml nymx-20181231.xsd nymx-20181231_cal.xml nymx-20181231_def.xml nymx-20181231_lab.xml nymx-20181231_pre.xml |